pericyte therapy
pericyte therapy, Total:43 items.
The international standard classification for "pericyte therapy" includes: Medical Sciences and health care facilities in general , Biology. Botany. Zoology , Medical materials .
The Chinese standard classification for "pericyte therapy" includes: Sanitation in general , Biological agent and blood products , Extracorporeal circulation, artificial organ and prosthesis device , Medical apparatus and devices in general .
Group Standards of the People's Republic of China
- T/CEAC 105-2025 TIL Cell Therapy Clinical Application Guidelines
- T/SBX 055-2022 Test methods for tumorigenicity of stem cell therapy products
- T/CSCB 0019-2024 Stem Cell Marker Molecular Detection Flow Cytometry
- T/SHSYCXH 8-2022 Test method of human Natural Killer cells and Natural Killer T cells from peripheral blood-Flow cytometry
- T/CEAC 069-2024 Cell therapy Leukopak raw material collection and immune cell separation technical requirements
- T/CEAC 059-2024 General requirements for detection of circulating tumor cells in peripheral blood
- T/SHSYCXH 13-2024 Detection of Regulatory T Cells in Peripheral Blood of Humans by Flow Cytometry
- T/CMBA 011-2020 Collection, Separation and Preservation of PBMC from Human Peripheral Blood
- T/SHSYCXH 14-2024 Detection of Neutrophils and nCD64 Index in Peripheral Blood by Flow Cytometry
- T/CSBM 0044-2023 Non-antibody-dependent magnetic separation detection method of circulating tumor cells in peripheral blood
- T/SHSYCXH 7-2022 Test method of human monocyte populations from peripheral blood-Flow cytometry
Professional Standard - Hygiene
- WS/T 360-2011 Guidelines for peripheral lymphocyte subsets by flow cytometry
- WS/T 360-2024 Guideline for enumeration of peripheral blood lymphocyte subsets by flow cytometry
- WS/T 245-2005 Reference method for the enumeration of erythrocytes and leucocytes
National Health Commission of the People's Republic of China
- WST 360:2011 Guidelines for detection of peripheral blood lymphocyte subsets by flow cytometry
Professional Standard - Agriculture
- 150药典 三部-2020 Monograph Ⅱ Therapeutic topical human granulocyte macrophage stimulating factor gel
- 149药典 三部-2020 Monograph II Therapeutic Human Granulocyte Macrophage Stimulating Factor for Injection
- 118药典 三部-2010 Chapter II Therapeutic Recombinant Human Granulocyte Macrophage Stimulating Factor for Injection
- 142药典 三部-2015 Monograph II Therapeutic Recombinant Human Granulocyte Macrophage Stimulating Factor for Injection
Jilin Provincial Standard of the People's Republic of China
- DB22/T 2853-2017 Peripheral Blood High Fluorescence Intensity Lymphocyte Percentage (HFLC%) Screening Technical Regulations for Atypical Lymphocytes
General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China
- GB/T 39729-2020 General requirements for measurement of cell purity—Flow cytometry
- GB/T 39730-2020 General requirements for cell counting—Flow cytometry
Professional Standard - Medicine
- YY/T 0606.13-2008 Tissue Engineered Medical Product - Part 13: Standard Test Method for Automated Enumeration of Cell Suspensions
- YY/T 1465.6-2019 Immunogenic evaluation method of medical devices―Part 6:Determination of animal spleen lymphocyte subsets by flow cytometry
- YY/T 1465.4-2017 Immunogenic evaluation method of medical devices-Part4:Phagocytosis of mouse peritoneal macrophages on chicken erythrocytes- Ex-vivo method
Shanghai Provincial Standard of the People's Republic of China
- DB31/T 687-2013 Basic requirements for clinical cell therapy platform settings
Hebei Provincial Standard of the People's Republic of China
- DB13/T 5332-2021 Technical specification for clinical operation of cellular immunotherapy
GCC Standardization Organization
- GSO ASTM F3206:2022 Standard Guide for Assessing Medical Device Cytocompatibility with Delivered Cellular Therapies
Kingdom of Bahrain Testing and Metrology Directorate
- BH GSO ASTM F3206:2023 Standard Guide for Assessing Medical Device Cytocompatibility with Delivered Cellular Therapies
American Society for Testing and Materials (ASTM)
- ASTM F3206-25 Standard Guide for Assessing Medical Device Cytocompatibility with Delivered Cellular Therapies
- ASTM F3206-17 Standard Guide for Assessing Medical Device Cytocompatibility with Delivered Cellular Therapies
- ASTM F3368-19 Standard Guide for Cell Potency Assays for Cell Therapy and Tissue Engineered Products
- ASTM D3576-20 Standard Test Method for Cell Size of Rigid Cellular Plastics
- ASTM F895-25 Standard Test Method for Agar Diffusion Cell Culture Screening for Cytotoxicity
- ASTM D3576-25 Standard Test Method for Cell Size of Rigid Cellular Plastics
British Standards Institution (BSI)
- BS PAS 84:2012 Cell therapy and regenerative medicine. Glossary
- BS PAS 83:2006 Guidance on codes of practice, standardised methods and regulations for cell-based therapeutics
- BS EN 30993-5:1994 Biological evaluation of medical devices-Tests for cytotoxicity, in vitro methods
- BS ISO 20391-1:2018 Biotechnology. Cell counting. General guidance on cell counting methods
Clinical and Laboratory Standards Institute
- NCCLS H7-A3-2000 Procedure for determination of hematocrit by microhematocrit method
American National Standards Institute （ANSI)
- ANSI/NCCLS H7-A 2-1996 Procedure for Determining Packed Cell Volume by the Microhematocrit Method
Korean Agency for Technology and Standards (KATS)
- KS P 1600-2018(2023) General guideline of safety test for the cell based therapeutic substances
- KS P 1600-2023 General guideline of safety test for the cell based therapeutic substances
Pericytes,cell therapy,cell therapy,cell-directed therapy,pericyte transfer,cell therapy,pericyte therapy,cell therapy,Novel Cell Therapy,target cell therapy,target cell therapy,Cell Regenerative Therapy,Various Cell Therapies,mononuclear cell therapy,Beijing Cell Therapy,medical cell therapy,polar pericytes,Therapy Cell Therapy,Cell Therapy+,multicellular therapy
